3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
4
Neuroblastoma
3
Medulloblastoma
2
Carcinoid Tumor
2
von Hippel-Lindau Disease
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Prostatic Neoplasms
1
Parathyroid Neoplasms
1
Paraganglioma
1
Multiple Endocrine Neoplasia
1
Hypoglycemia
1
Hyperparathyroidism
1
Hypercalcemia
1
Cancer Diagnosis
1
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
Fluorodeoxyglucose F18
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tanespimycin
1
romidepsin
1
pembrolizumab
1
omipalisib
1
durvalumab
1
dabrafenib
1
cediranib
1
aflibercept
1
Vorinostat
1
Thyrotropin Alfa
1
Specimen Handling
1
Sorafenib
1
Pharmacogenomic Testing
1
Nivolumab
1
Lenalidomide
1
Ipilimumab
1
Iodine-124
1
Gefitinib
1
Decitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Follicular
×
gallium Ga 68 dotatate
×
Clear all
No trials found.